Omnicell Inc (OMCL) News

Form 8-K - Current report

Omnicell Announces Third Quarter 2024 Results

Omnicell delivers solid third quarter financial results Total revenues of $282 million GAAP net income per diluted share of $0.19 Non-GAAP net...

Form 3 - Initial statement of beneficial ownership of securities

Omnicell to Release Third Quarter 2024 Financial Results on October 30, 2024

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the third quarter...

Form 8-K - Current report

Omnicell Appoints Nnamdi Njoku as Executive Vice President and Chief Operating Officer

The Company taps business and operations executive with expertise that spans healthcare and med tech to help...

Form 4 - Statement of changes in beneficial ownership of securities

Omnicell Announces Central Med Automation Service

Full-Service, Scalable Solution Designed to Help Health Systems Establish and Continuously Optimize...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Omnicell to Present at the 2024 Wells Fargo Healthcare Conference

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the 2024 Wells Fargo...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

EnlivenHealth® and Good Neighbor Pharmacy® Seek to Empower Independent Pharmacies with New Clinical Scope of Practice and Reimbursement Solution

Good Neighbor Pharmacy Launches EnlivenHealth’s New Scope of Practice and Reimbursement Snapshot at ThoughtSpot Designed to Drive Clinical...